clinical trials | iPharmaCenter

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

Merck announced trial results of gefapixant in patients with refractory or unexplained chronic cough

ipharmaservices

Sep 11, 2020

Merck announced trial results of gefapixant in patients with refractory or unexplained chronic cough

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page